Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First patient dosing enables closing of $100 million PIPE financing and drawdown of $20 million term loan trancheMINNEAPOLIS, MN / ACCESSWIRE / December 7, 2022 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage
Concurrent with the merger, Enliven plans to raise $165 million in a private financing, and the joint company is expected to have $300 million in cash and cash equivalents.
NEW YORK, Oct. 10, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ('Immunic' or the 'Company'), a clinical-stage biopharmaceutical company deve...
The drugmaker announced a $75 million public offering.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) Director Simon N. Pimstone sold 33,942 shares of the company’s stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $37.76, for a total transaction of $1,281,649.92. Following the transaction, the director now owns 58,058 shares in the company, valued at […]